| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.24 | 7e-10 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.2 | 4e-09 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-09 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.19 | 8e-08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-07 |